Trading Suspension Due to Capital Reduction
-
KOSDAQ Market Division suspended trading of NGeneBio common stocks from 15:46 on April 27, 2026 until market close due to capital reduction
-
Basis: KOSDAQ Market Disclosure Regulation Article 37 and same regulation Enforcement Rules Article 18
-
Pre-opening after-hours trading on the resumption date is not permitted
KOSDAQ Filing Information
-
Filing: Suspension of Stock Trading (Capital Reduction)
-
Company: NGeneBio (354200)
-
Submission: KOSDAQ Market Division
-
Receipt: 04-27-2026
-
Under KRX KOSDAQ Market Division